Petros Pharmaceuticals Inc. (NASDAQ: PTPI) At Current Prices: Is It Worth Investing In?

During the last session, Petros Pharmaceuticals Inc. (NASDAQ:PTPI)’s traded shares were 3.72 million. At the end of the trading day, the stock’s price was $2.68, reflecting an intraday loss of -9.15% or -$0.27. The 52-week high for the PTPI share is $5.20, that puts it down -94.03 from that peak though still a striking 55.6% gain since the share price plummeted to a 52-week low of $1.19. The company’s market capitalization is $47.97M, and the average trade volume was 17.88 million shares over the past three months.

Petros Pharmaceuticals Inc. (PTPI) registered a -9.15% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -9.15% in intraday trading to $2.68 this Wednesday, 01/05/22, hitting a weekly high. The stock’s 5-day price performance is -26.37%, and it has moved by 22.37% in 30 days. Based on these gigs, the overall price performance for the year is -39.09%.

3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

While earnings are projected to return 36.70% in 2022.

PTPI Dividends

Petros Pharmaceuticals Inc. is due to release its next quarterly earnings on May 17. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Petros Pharmaceuticals Inc. (NASDAQ:PTPI)’s Major holders

Petros Pharmaceuticals Inc. insiders own 39.31% of total outstanding shares while institutional holders control 7.20%, with the float percentage being 11.86%. Shay Capital LLC is the largest shareholder of the company, while 22 institutions own stock in it. As of Sep 29, 2021, the company held over 0.28 million shares (or 1.54% of all shares), a total value of $0.56 million in shares.

The next largest institutional holding, with 0.12 million shares, is of Northrock Partners, Llc’s that is approximately 0.64% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $0.23 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also, the Mutual Funds coming in first place with the largest holdings of Petros Pharmaceuticals Inc. (PTPI) shares are Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund. Data provided on Sep 29, 2021 indicates that Vanguard Extended Market Index Fund owns about 64076.0 shares. This amounts to just over 0.36 percent of the company’s overall shares, with a $0.13 million market value. The same data shows that the other fund manager holds slightly less at 43424.0, or about 0.24% of the stock, which is worth about $86848.0.